The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology
Open accessAbstract
Iron is an essential nutrient that plays a complex role in cancer biology. Iron metabolism must be tightly controlled within cells. Whilst fundamental to many cellular processes and required for cell survival, excess labile iron is toxic to cells. Increased iron metabolism is associated with malignant transformation, cancer progression, drug resistance and immune evasion. Depleting intracellular iron stores, either with the use of iron chelating agents or mimicking endogenous regulation mechanisms, such as microRNAs, present attractive therapeutic opportunities, some of which are currently under clinical investigation. Alternatively, iron overload can result in a form of regulated cell death, ferroptosis, which can be activated in cancer cells presenting an alternative anti-cancer strategy. This review focuses on alterations in iron metabolism that enable cancer cells to meet metabolic demands required during different stages of tumorigenesis in relation to metastasis and immune response. The strength of current evidence is considered, gaps in knowledge are highlighted and controversies relating to the role of iron and therapeutic targeting potential are discussed. The key question we address within this review is whether iron modulation represents a useful approach for treating metastatic disease and whether it could be employed in combination with existing targeted drugs and immune-based therapies to enhance their efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Mihailidou, C., Papakotoulas, P., Papavassiliou, A. G., & Karamouzis, M. V. (2017) · Oncotarget · doi:10.18632/oncotarget.23164 · Cited by 33
RetractedChen, Z., Sun, J. P., Li, T., Liu, Y., Gao, S., Zhi, X., & Zheng, M. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.054 · Cited by 23
RetractedRegulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1170-y · Cited by 2,880
Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013) · The AAPS Journal · doi:10.1208/s12248-012-9432-8 · Cited by 2,110
Ferroptosis is an autophagic cell death process
Gao, M., Monian, P., Pan, Q., Zhang, W., Xiang, J., & Jiang, X. (2016) · Cell Research · doi:10.1038/cr.2016.95 · Cited by 1,899
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J. S., Nejadnik, H., Goodman, S., Moseley, M., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.168 · Cited by 1,647
Iron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621
Hodi, F. S., Chiarion-Sileni, V., Gonzalez, R., Grob, J.-J., Rutkowski, P., Cowey, C. L., Lao, C. D., Schadendorf, D., Wagstaff, J., Dummer, R., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30700-9 · Cited by 1,399 · cited 1×
“Assessment of patient tissues with CD163-positive tumor cells correlated with higher tumor grade, invasiveness, radioresistance and poor progression free- and overall survival in melanoma (111), breast (54, 112, 113), CRC (113), renal cell (114), and gastric (115) carcinomas.”
BackgroundThe metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Mechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,047
Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
Bogdan, A. R., Miyazawa, M., Hashimoto, K., & Tsuji, Y. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.11.012 · Cited by 893
The transferrin receptor and the targeted delivery of therapeutic agents against cancer
Daniels, T. R., Bernabeu, E., Rodríguez, J. A., Patel, S., Kozman, M., Chiappetta, D. A., Holler, E., Ljubimova, J. Y., Helguera, G., & Penichet, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.07.016 · Cited by 807
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Guo, J., Xu, B., Han, Q., Zhou, H., Xia, Y., Gong, C., Dai, X., Li, Z., & Wu, G. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2016.572 · Cited by 777
The Roles of NRF2 in Modulating Cellular Iron Homeostasis
Kerins, M. J., & Ooi, A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7176 · Cited by 738
Defining the Hallmarks of Metastasis
Welch, D. R., & Hurst, D. R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0458 · Cited by 700
Characterization of ferroptosis in murine models of hemochromatosis
Wang, H., An, P., Xie, E., Wu, Q., Fang, X., Gao, H., Zhang, Z., Li, Y., Wang, X., Zhang, J., et al. (2017) · Hepatology · doi:10.1002/hep.29117 · Cited by 660
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma
Hassannia, B., Wiernicki, B., Ingold, I., Qu, F., Van Herck, S., Tyurina, Y. Y., Bayır, H., Abhari, B. A., Angeli, J. P. F., Choi, S. M., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99032 · Cited by 627
Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells
Ma, S., Henson, E. S., Chen, Y., & Gibson, S. B. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.208 · Cited by 622
Dixon, S. J., & Stockwell, B. R. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030518-055844 · Cited by 577
Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea
Du, G.-J., Zhang, Z., Wen, X.-D., Yu, C., Calway, T., Yuan, C.-S., & Wang, C.-Z. (2012) · Nutrients · doi:10.3390/nu4111679 · Cited by 531
Intracellular iron transport and storage: from molecular mechanisms to health implications
Mackenzie, E. L., Iwasaki, K., & Tsuji, Y. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1893 · Cited by 526
Whitnall, M., Howard, J., Ponka, P., & Richardson, D. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604979103 · Cited by 509
Transferrin receptor 1 in cancer: a new sight for cancer therapy.
Shen, Y., Li, X., Dong, D., Zhang, B., Xue, Y., & Shang, P. (2018) · Europe PMC (PubMed Central) · Cited by 483
Mechanisms of Motility in Metastasizing Cells
Yilmaz, M., & Christofori, G. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0139 · Cited by 477
Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis
Pinnix, Z. K., Miller, L. D., Wang, W., D’Agostino, R., Kute, T., Willingham, M. C., Hatcher, H., Tesfay, L., Sui, G., Di, X., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001127 · Cited by 448
The Role of Ferroptosis in Cancer Development and Treatment Response
Lu, B., Chen, X. B., Ying, M. D., He, Q. J., Cao, J., & Yang, B. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00992 · Cited by 444
Regulation of the Iron Homeostatic Hormone Hepcidin
Sangkhae, V., & Nemeth, E. (2017) · Advances in Nutrition · doi:10.3945/an.116.013961 · Cited by 443
Mitochondria and Iron: current questions
Paul, B. T., Manz, D. H., Torti, F. M., & Torti, S. V. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2016.1268047 · Cited by 423
Effects of exosomes on pre-metastatic niche formation in tumors
Guo, Y., Ji, X., Liu, J., Fan, D., Zhou, Q., Chen, C., Wang, W., Wang, G., Wang, H., Yuan, W., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0995-1 · Cited by 401
Lane, D. J. R., Merlot, A. M., Huang, M. L.-H., Bae, D.-H., Jansson, P. J., Sahni, S., Kalinowski, D. S., & Richardson, D. R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.01.021 · Cited by 399 · cited 1×
“Iron is required in the mitochondria for synthesis of heme and Fe-S clusters, both of which are essential cofactors in energy production through transfer of electrons between mitochondrial respiratory complexes (7).”
BackgroundSilybin and the liver: From basic research to clinical practice
Loguercio, C. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i18.2288 · Cited by 375
Finch, R. A., Liu, M.-C., Grill, S. P., Rose, W. C., Loomis, R., Vasquez, K. M., Cheng, Y.-C., & Sartorelli, A. C. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00419-0 · Cited by 366
The elemental role of iron in DNA synthesis and repair
Puig, S., Ramos-Alonso, L., Romero, A. M., & Martínez-Pastor, M. T. (2017) · Metallomics · doi:10.1039/c7mt00116a · Cited by 362
Lipocalin 2 promotes breast cancer progression
Yang, J., Bielenberg, D. R., Rodig, S. J., Doiron, R., Clifton, M. C., Kung, A. L., Strong, R. K., Zurakowski, D., & Moses, M. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810617106 · Cited by 356
Oxidative Stress and Iron Homeostasis: Mechanistic and Health Aspects
Galaris, D., & Pantopoulos, K. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701713104 · Cited by 352 · cited 1×
“ROS are targeted by antioxidant systems which reduce them to non-reactive H2O before damage ensues (17).”
BackgroundYanatori, I., & Kishi, F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.020 · Cited by 351
Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells
Schonberg, D. L., Miller, T. E., Wu, Q., Flavahan, W. A., Das, N. K., Hale, J. S., Hubert, C. G., Mack, S. C., Jarrar, A. M., Karl, R. T., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.002 · Cited by 349
Exosomal Tumor MicroRNA Modulates Premetastatic Organ Cells
Rana, S., Malinowska, K., & Zöller, M. (2013) · Neoplasia · doi:10.1593/neo.122010 · Cited by 346
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
Jia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816391116 · Cited by 336
A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients
Flaig, T. W., Gustafson, D. L., Su, L.-J., Zirrolli, J. A., Crighton, F., Harrison, G. S., Pierson, A. S., Agarwal, R., & Glodé, L. M. (2007) · Investigational New Drugs · doi:10.1007/s10637-006-9019-2 · Cited by 315
Body iron stores and risk of cancer
Knekt, P., Reunanen, A., Takkunen, H., Aromaa, A., Heliövaara, M., & Hakuunen, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560315 · Cited by 314
The Role of Iron Regulation in Immunometabolism and Immune-Related Disease
Cronin, S. J. F., Woolf, C. J., Weiss, G., & Penninger, J. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00116 · Cited by 299
Moderate elevation of body iron level and increased risk of cancer occurrence and death
Stevens, R. G., Graubard, B. I., Micozzi, M. S., Neriishi, K., & Blumberg, B. S. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560312 · Cited by 277
Iron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268
Jiao, Y., Wilkinson, J., Di, X., Wang, W., Hatcher, H., Kock, N. D., D'Agostino, R., Knovich, M. A., Torti, F. M., & Torti, S. V. (2009) · Blood · doi:10.1182/blood-2008-05-155952 · Cited by 266 · cited 2×
“Curcumin, derived from the plant Curcuma longa, has long been used in traditional medicine, but has also shown efficacy against colon, duodenal, stomach, esophageal, and oral cancers (222).”
BackgroundZhang, X., Fryknäs, M., Hernlund, E., Fayad, W., De Milito, A., Olofsson, M. H., Gogvadze, V., Dang, L., Påhlman, S., Schughart, L. A. K., et al. (2014) · Nature Communications · doi:10.1038/ncomms4295 · Cited by 253
Activation of Transferrin Receptor 1 by c-Myc Enhances Cellular Proliferation and Tumorigenesis
O'Donnell, K. A., Yu, D., Zeller, K. I., Kim, J.-W., Racke, F., Thomas-Tikhonenko, A., & Dang, C. V. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2373-2386.2006 · Cited by 253
Chen, Z., Zhang, D., Yue, F., Zheng, M., Kovacevic, Z., & Richardson, D. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350470 · Cited by 248
Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.
Brown, J. P., Woodbury, R. G., Hart, C. E., Hellström, I., & Hellström, K. E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.1.539 · Cited by 247
The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis
Alkhateeb, A. A., & Connor, J. R. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.07.002 · Cited by 246
Xue, X., Ramakrishnan, S. K., Weisz, K., Triner, D., Xie, L., Attili, D., Pant, A., Győrffy, B., Zhan, M., Carter-Su, C., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.015 · Cited by 245
Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
Xu, L., Huang, C., Huang, W., Tang, W., Rait, A. S., Yin, Y. Z., Cruz, I., Xiang, L., Pirollo, K. F., & Chang, E. H. (2002) · PubMed · Cited by 243
McLarty, J., Bigelow, R. L. H., Smith, M., Elmajian, D., Ankem, M., & Cardelli, J. A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0167 · Cited by 235
Modulation of iron transport proteins in human colorectal carcinogenesis
Brookes, M. J., Hughes, S., Turner, F. E., Reynolds, G., Sharma, N., Ismail, T., Berx, G., McKie, A. T., Hotchin, N., Anderson, G. J., et al. (2006) · Gut · doi:10.1136/gut.2006.094060 · Cited by 226
Shabo, I., Stål, O., Olsson, H., Doré, S., & Svanvik, J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23527 · Cited by 225
Brenneisen, P., Wenk, J., Klotz, L. O., Wlaschek, M., Briviba, K., Krieg, T., Sies, H., & Scharffetter-Kochanek, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.5279 · Cited by 223
Kalinowski, D. S., Yu, Sharpe, P. C., Islam, M., Liao, Y.-T., Lovejoy, D. B., Kumar, N., Bernhardt, P. V., & Richardson, D. R. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070445z · Cited by 222
Krishna, S., Ganapathi, S., Ster, I. C., Saeed, M. E. M., Cowan, M., Finlayson, C., Kovacsevics, H., Jansen, H., Kremsner, P. G., Efferth, T., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2014.11.010 · Cited by 214
STEAP Proteins: From Structure to Applications in Cancer Therapy
Gomes, I. M., Maia, C. J., & Santos, C. R. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0281 · Cited by 211
Iannetti, A., Pacifico, F., Acquaviva, R., Lavorgna, A., Crescenzi, E., Vascotto, C., Tell, G., Salzano, A. M., Scaloni, A., Vuttariello, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710846105 · Cited by 210
Ghanbari Movahed, Z., Rastegari-Pouyani, M., Mohammadi, M. H., & Mansouri, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108690 · Cited by 208
Role of ferritin alterations in human breast cancer cells
Shpyleva, S. I., Tryndyak, V. P., Kovalchuk, O., Starlard-Davenport, A., Chekhun, V. F., Beland, F. A., & Pogribny, I. P. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0849-4 · Cited by 206
Lovejoy, D. B., Sharp, D. M., Seebacher, N., Obeidy, P., Prichard, T., Stefani, C., Basha, M. T., Sharpe, P. C., Jansson, P. J., Kalinowski, D. S., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300768u · Cited by 201
Regulation of Lung Cancer Cell Migration and Invasion by Reactive Oxygen Species and Caveolin-1
Luanpitpong, S., Talbott, S. J., Rojanasakul, Y., Nimmannit, U., Pongrakhananon, V., Wang, L., & Chanvorachote, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.124958 · Cited by 201
Effects of a single course of deferoxamine in neuroblastoma patients.
Donfrancesco, A., Deb, G., Dominici, C., Pileggi, D., Castello, M. A., & Helson, L. (1990) · PubMed · Cited by 196
Flaig, T. W., Glodé, M., Gustafson, D., van Bokhoven, A., Tao, Y., Wilson, S., Su, L., Li, Y., Harrison, G., Agarwal, R., et al. (2010) · The Prostate · doi:10.1002/pros.21118 · Cited by 193
Hypoxia-inducible factors link iron homeostasis and erythropoiesis
Shah, Y. M., & Xie, L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.031 · Cited by 187
Eberhard, Y., McDermott, S. P., Wang, X., Gronda, M., Venugopal, A., Wood, T. E., Hurren, R., Datti, A., Batey, R. A., Wrana, J., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209965 · Cited by 183
Kovacevic, Z., Chikhani, S., Lovejoy, D. B., & Richardson, D. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073627 · Cited by 177
Specific iron chelators determine the route of ferritin degradation
De Domenico, I., Ward, D. M., & Kaplan, J. (2009) · Blood · doi:10.1182/blood-2009-05-224188 · Cited by 176
Transferrin receptor 2 is frequently expressed in human cancer cell lines
Calzolari, A., Oliviero, I., Deaglio, S., Mariani, G., Biffoni, M., Sposi, N. M., Malavasi, F., Peschle, C., & Testa, U. (2007) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2007.02.003 · Cited by 171
Lovejoy, D. B., & Richardson, D. R. (2002) · Blood · doi:10.1182/blood.v100.2.666 · Cited by 168
Regulatory effects of ferritin on angiogenesis
Coffman, L. G., Parsonage, D., D'Agostino, R., Torti, F. M., & Torti, S. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812010106 · Cited by 168
Tong, Z., Kunnumakkara, A. B., Wang, H., Matsuo, Y., Diagaradjane, P., Harikumar, K. B., Ramachandran, V., Sung, B., Chakraborty, A., Bresalier, R. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0540 · Cited by 165
Marcus, D. M., & Zinberg, N. (1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/55.4.791 · Cited by 164
Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan
Bailey, H. H., Ripple, G., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Mahvi, D., Schink, J., Pomplun, M., Mulcahy, R. T., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1789 · Cited by 164
Gomez-Chou, S. B., Swidnicka-Siergiejko, A. K., Badi, N., Chavez-Tomar, M., Lesinski, G. B., Bekaii-Saab, T., Farren, M. R., Mace, T. A., Schmidt, C., Liu, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1986 · Cited by 162
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Lui, G. Y. L., Kovacevic, Z., Richardson, V., Merlot, A. M., Kalinowski, D. S., & Richardson, D. R. (2015) · Oncotarget · doi:10.18632/oncotarget.4349 · Cited by 161
HANN, H.-W. L., Evans, A. E., Siegel, S. E., Wong, K. Y., Sather, H. N., Dalton, A., Hammond, D., & Seeger, R. C. (1985) · PubMed · Cited by 160
CCL2 is critical for immunosuppression to promote cancer metastasis
Kudo‐Saito, C., Shirako, H., Ohike, M., Tsukamoto, N., & Kawakami, Y. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9545-6 · Cited by 157
Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy
Granja, A., Pinheiro, M., & Reis, S. (2016) · Nutrients · doi:10.3390/nu8050307 · Cited by 156
Wnt Inhibitor Screen Reveals Iron Dependence of β-Catenin Signaling in Cancers
Song, S., Christova, T. Y., Perusini, S. J., Alizadeh, S., Bao, R.-Y., Miller, B. W., Hurren, R., Jitkova, Y., Gronda, M., Isaac, M. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2745 · Cited by 152
Iron in the Tumor Microenvironment-Connecting the Dots
Pfeifhofer-Obermair, C., Tymoszuk, P., Petzer, V., Weiss, G., & Nairz, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00549 · Cited by 151
Iron homeostasis and tumorigenesis: molecular mechanisms and therapeutic opportunities
Zhang, C., & Zhang, F. (2014) · Protein & Cell · doi:10.1007/s13238-014-0119-z · Cited by 149
Brown, R. A. M., Epis, M. R., Horsham, J. L., Kabir, T. D., Richardson, K. L., & Leedman, P. J. (2018) · BMC Biotechnology · doi:10.1186/s12896-018-0421-6 · Cited by 145
Self-citationNuclear ferritin: A new role for ferritin in cell biology
Alkhateeb, A. A., & Connor, J. R. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.03.017 · Cited by 143
Interactions in the (Pre)metastatic Niche Support Metastasis Formation
Doglioni, G., Parik, S., & Fendt, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00219 · Cited by 143
Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin
Sangokoya, C., Doss, J. F., & Chi, J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003408 · Cited by 142
IRP2 Regulates Breast Tumor Growth
Wang, W., Deng, Z., Hatcher, H., Miller, L. D., Di, X., Tesfay, L., Sui, G., D'Agostino, R. B., Torti, F. M., & Torti, S. V. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1224 · Cited by 141
Cao, H., Wang, C., Chen, X., Hou, J., Xiang, Z., Shen, Y., & Han, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-28968-9 · Cited by 141
A role for iron in Wnt signalling
Brookes, M. J., Boult, J., Roberts, K., Cooper, B. T., Hotchin, N. A., Matthews, G., Iqbal, T., & Tselepis, C. (2008) · Oncogene · doi:10.1038/sj.onc.1210711 · Cited by 139
Boult, J. K. R., Roberts, K., Brookes, M., Hughes, S., Bury, J. P., Cross, S. S., Anderson, G. J., Spychal, R., Iqbal, T. H., & Tselepis, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1054 · Cited by 135
Transferrin Receptor 2 Is Frequently and Highly Expressed in Glioblastomas
Calzolari, A., Larocca, L. M., Deaglio, S., Finisguerra, V., Boe, A., Raggi, C., Ricci-Vitani, L., Pierconti, F., Malavasi, F., Maria, R. D., et al. (2010) · Translational Oncology · doi:10.1593/tlo.09274 · Cited by 132
Cat, B., Stuhlmann, D., Steinbrenner, H., Alili, L., Holtkötter, O., Sies, H., & Brenneisen, P. (2006) · Journal of Cell Science · doi:10.1242/jcs.03011 · Cited by 132
Lipocalin 2: A multifaceted modulator of human cancer
Yang, J., & Moses, M. A. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9224 · Cited by 131
Oh, S. K. W., Kim, B. J., Singh, N. P., Lai, H. C., & Sasaki, T. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.031 · Cited by 131
Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer
Prutki, M., Poljak‐Blaži, M., Jakopović, M., Tomas, D., Stipančić, I., & Žarković, N. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.07.001 · Cited by 129
Guo, Z.-L., Richardson, D. R., Kalinowski, D. S., Kovačević, Ž., Tan-Un, K. C., & Chan, G. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0330-x · Cited by 127
Kabir, T. D., Ganda, C., Brown, R. A. M., Beveridge, D. J., Richardson, K. L., Chaturvedi, V., Candy, P. A., Epis, M. R., Wintle, L. C., Kalinowski, F. C., et al. (2017) · Hepatology · doi:10.1002/hep.29478 · Cited by 123
Self-citationOxidative stress-induced angiogenesis
Huang, Y., & Nan, G. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.02.019 · Cited by 123
Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells
Gray, C. P., Arosio, P., & Hersey, P. (2002) · Blood · doi:10.1182/blood.v99.9.3326 · Cited by 118
Expression of Macrophage Antigens by Tumor Cells
Shabo, I., & Svanvik, J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0782-5_7 · Cited by 117
Seebacher, N. A., Richardson, D. R., & Jansson, P. J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.381 · Cited by 116
Hu, L., Hittelman, W. N., Lu, T., Ji, P., Arlinghaus, R. B., Ilya Shmulevich, C., Hamilton, S. R., & Zhang, W. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.17 · Cited by 114
Jeong, S. M., Hwang, S., & Seong, R. H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.023 · Cited by 114
miR-20a regulates expression of the iron exporter ferroportin in lung cancer
Babu, K. R., & Muckenthaler, M. U. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1362-3 · Cited by 113
Gibbons, J. A., Kanwar, J. R., & Kanwar, R. K. (2015) · BMC Cancer · doi:10.1186/s12885-015-1441-4 · Cited by 112
Dixon, K. A., Lui, G. Y. L., Kovačević, Ž., Zhang, D., Mu, Y., Chen, Z., Dong, Q., Assinder, S. J., & Richardson, D. R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.582 · Cited by 112
Cancer: fundamentals behind pH targeting and the double-edged approach
Koltai, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s115438 · Cited by 111
The antitumor activity of the fungicide ciclopirox
Zhou, H., Shen, T., Luo, Y., Liu, L., Chen, W., Xu, B., Han, X., Pang, J., Rivera, C. A., & Huang, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25255 · Cited by 109
Yu, Y., Rahmanto, Y. S., & Richardson, D. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01526.x · Cited by 108
A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
Deeken, J. F., Wang, H., Hartley, M. L., Cheema, A. K., Smaglo, B. G., Hwang, J. J., He, A. R., Weiner, L. M., Marshall, J. L., Giaccone, G., et al. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3533-8 · Cited by 107
Zhou, Y., Zeng, Z., Zhang, W., Xiong, W., Wu, M., Tan, Y., Yi, W., Xiao, L., Li, X., Huang, C., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23727 · Cited by 105
Andolfo, I., Falco, L. D., Asci, R., Russo, R., Colucci, S., Gorrese, M., Zollo, M., & Iolascon, A. (2010) · Haematologica · doi:10.3324/haematol.2009.020685 · Cited by 103
Akatsuka, S., Yamashita, Y., Ohara, H., Liu, Y.-T., Izumiya, M., Abe, K., Ochiai, M., Jiang, L., Nagai, H., Okazaki, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043403 · Cited by 102
Cho, H., & Kim, J. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953257 · Cited by 101
The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis
Dunn, L., Sekyere, E. O., Rahmanto, Y. S., & Richardson, D. R. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl045 · Cited by 99
New insights into the links between hypoxia and iron homeostasis
Renassia, C., & Peyssonnaux, C. (2019) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000494 · Cited by 99
Tumor Cell Cytotoxicity of a Novel Metal Chelator
Torti, S. V., Torti, F. M., Whitman, S. P., Brechbiel, M. W., Park, G., & Planalp, R. P. (1998) · Blood · doi:10.1182/blood.v92.4.1384 · Cited by 98
Lactoferrin and Cancer Disease Prevention
Rodrigues, L. R., Teixeira, J. A., Schmitt, F. C., Paulsson, M. A., & Månsson, H. L. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390701856157 · Cited by 97
Villablanca, J. G., Volchenboum, S. L., Cho, H., Kang, M. H., Cohn, S. L., Anderson, C. P., Marachelian, A., Groshen, S. G., Tsao-Wei, D. D., Matthay, K. K., et al. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.25994 · Cited by 96
CPX Targeting DJ-1 Triggers ROS-induced Cell Death and Protective Autophagy in Colorectal Cancer
Zhou, J., Zhang, L., Wang, M., Zhou, L., Feng, X., Yu, L., Lan, J., Gao, W. Q., Zhang, C., Bu, Y., et al. (2019) · Theranostics · doi:10.7150/thno.34663 · Cited by 96
MicroRNA-152-mediated dysregulation of hepatic transferrin receptor 1 in liver carcinogenesis
Kindrat, I., Tryndyak, V., de Conti, A., Shpyleva, S., Mudalige, T., Kobets, T., Еrstenyuk, H. M., Beland, F. A., & Pogribny, I. P. (2015) · Oncotarget · doi:10.18632/oncotarget.6004 · Cited by 95
Transferrin receptor 2: a new molecule in iron metabolism
Trinder, D., & Baker, E. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00258-3 · Cited by 94 · cited 2×
“TfR2 lacks an IRE sequence so its expression is not directly regulated by iron levels (103).”
BackgroundSelf-citationBaldi, A., Lombardi, D., Russo, P., Palescandolo, E., Luca, A. D., Santini, D., Baldi, F., Rossiello, L., Dell’Anna, M. L., Mastrofrancesco, A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0631 · Cited by 92
PRIMA-1Met/APR-246 Displays High Antitumor Activity in Multiple Myeloma By Induction of p73 and Noxa
Saha, M. N., Jiang, H., Yang, Y., Reece, D., & Chang, H. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1166 · Cited by 91
Feng, M., Feng, J., Chen, W., Wang, W., Wu, X., Zhang, J., Xu, F., & Lai, M. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0564-9 · Cited by 91
Jian, J., Yang, Q., Dai, J., Eckard, J., Axelrod, D., Smith, J. A., & Huang, X. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.028 · Cited by 90
Jiang, X. P., Elliott, R. L., & Head, J. F. (2010) · PubMed · Cited by 89
Lang, J., Zhao, X., Wang, X., Zhao, Y., Li, Y., Zhao, R., Cheng, K., Li, Y., Han, X., Zheng, X., et al. (2019) · ACS Nano · doi:10.1021/acsnano.8b08823 · Cited by 89
Jung, M., Ören, B., Mora, J., Mertens, C., Dziumbla, S., Popp, R., Weigert, A., Grossmann, N., Fleming, I., & Brüne, B. (2016) · Science Signaling · doi:10.1126/scisignal.aaf3241 · Cited by 87
An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis
Guo, W., Zhang, S., Chen, Y., Zhang, D., Yuan, L., Cong, H., & Liu, S. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv063 · Cited by 86
Macrophage-derived lipocalin-2 transports iron in the tumor microenvironment
Mertens, C., Mora, J., Ören, B., Grein, S., Winslow, S., Scholich, K., Weigert, A., Malmström, P., Forsare, C., Fernö, M., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1408751 · Cited by 85
Mertens, C., Akam, E. A., Rehwald, C., Brüne, B., Tomat, E., & Jung, M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166164 · Cited by 83
Deferasirox ( ICL670A ) effectively inhibits oesophageal cancer growth in vitro and in vivo
Ford, S., Obeidy, P., Lovejoy, D. B., Bedford, M., Nichols, L., Chadwick, C., Tucker, O., Lui, G., Kalinowski, D. S., Jansson, P. J., et al. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12045 · Cited by 83
p53-independent apoptosis mediated by tachpyridine, an anti-cancer iron chelator
Abeysinghe, R. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.10.1607 · Cited by 83
Wang, J., Yin, D., Xie, C., Zheng, T., Liang, Y., Hong, X., Lu, Z., Song, X., Song, R., Yang, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2328 · Cited by 82
Iron chelators target both proliferating and quiescent cancer cells
Fryknäs, M., Zhang, X., Bremberg, U., Senkowski, W., Olofsson, M. H., Brandt, P., Persson, I., D’Arcy, P., Gullbo, J., Nygren, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38343 · Cited by 82
Lipocalin 2: a potential therapeutic target for breast cancer metastasis
Hu, C., Yang, K., Li, M., Huang, W., Zhang, F., & Wang, H. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s181223 · Cited by 82
Turner, J., Koumenis, C., Kute, T. E., Planalp, R. P., Brechbiel, M. W., Beardsley, D., Cody, B., Brown, K. D., Torti, F. M., & Torti, S. V. (2005) · Blood · doi:10.1182/blood-2005-03-1263 · Cited by 80
The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
Vosooghi, M., & Amini, M. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.883377 · Cited by 79
Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells
Pithi Chanvorachote, B., & Luanpitpong, S. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00322.2015 · Cited by 79
Perturbation of Iron Metabolism by Cisplatin through Inhibition of Iron Regulatory Protein 2
Miyazawa, M., Bogdan, A. R., & Tsuji, Y. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.10.009 · Cited by 78
Ma, J., Haldar, S., Khan, M. A., Sharma, S. D., Merrick, W. C., Theil, E. C., & Goss, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120045109 · Cited by 74
Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface
Rolland, Y., Demeule, M., Fénart, L., & Béliveau, R. (2008) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2008.00525.x · Cited by 74
Roles of low-density lipoprotein receptor-related protein 1 in tumors
Xing, P., Liao, Z., Ren, Z., Zhao, J. L., Song, F., Wang, G., Chen, K., & Yang, J. (2016) · 癌症:英文版 · doi:10.1186/s40880-015-0064-0 · Cited by 74
Fe‐S Clusters Emerging as Targets of Therapeutic Drugs
Vernis, L., Banna, N. E., Baïlle, D., Hatem, E., Heneman-Masurel, A., & Huang, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3647657 · Cited by 74
Richardson, D. R. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01079.x · Cited by 73
Iron Homeostasis Regulates the Activity of the MicroRNA Pathway through Poly(C)-Binding Protein 2
Li, Y., Lin, L., Li, Z., Ye, X., Xiong, K., Aryal, B., Xu, Z., Paroo, Z., Liu, Q., He, C., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.021 · Cited by 73
The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers
Tury, S., Assayag, F., Bonin, F., Château‐Joubert, S., Servely, J., Vacher, S., Becette, V., Caly, M., Rapinat, A., Gentien, D., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5104 · Cited by 72
Menezes, S. V., Fouani, L., Huang, M., Geleta, B., Maleki, S., Richardson, A., Richardson, D. R., & Kovačević, Ž. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy178 · Cited by 71
Metastatic growth instructed by neutrophil-derived transferrin
Liang, W. P., Li, Q., & Ferrara, N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811717115 · Cited by 70
Biamonte, F., Battaglia, A. M., Zolea, F., Oliveira, D. M., Aversa, I., Santamaria, G., Giovannone, E. D., Rocco, G., Viglietto, G., & Costanzo, F. S. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1216-3 · Cited by 68
Blanchette-Farra, N., Kita, D., Konstorum, A., Tesfay, L., Lemler, D. J., Hegde, P., Claffey, K. P., Torti, F. M., & Torti, S. V. (2018) · Oncogene · doi:10.1038/s41388-018-0243-y · Cited by 67
Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition
Sottile, R., Federico, G., Garofalo, C., Tallerico, R., Faniello, M. C., Quaresima, B., Cristiani, C. M., Sanzo, M. D., Cuda, G., Ventura, V., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00224 · Cited by 67
The Iron Chelator L1 Potentiates Oxidative DNA Damage in Iron-Loaded Liver Cells
Cragg, L., Hebbel, R. P., Miller, W. J., Solovey, A., Selby, S. A., & Enright, H. (1998) · Blood · doi:10.1182/blood.v92.2.632 · Cited by 66
Rahmanto, Y. S., Dunn, L., & Richardson, D. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210442 · Cited by 66
Influence of microRNA on the Maintenance of Human Iron Metabolism
Davis, M. R., & Clarke, S. L. (2013) · Nutrients · doi:10.3390/nu5072611 · Cited by 66
MiR-107 function as a tumor suppressor gene in colorectal cancer by targeting transferrin receptor 1
Fu, Y., Lin, L., & Xia, L. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0155-z · Cited by 66
Kaomongkolgit, R., Cheepsunthorn, P., Pavasant, P., & Sanchavanakit, N. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.08.005 · Cited by 65
Liu, N. Q., Marchi, T. D., Timmermans, A. M., Beekhof, R., Trapman-Jansen, A., Foekens, R., Look, M. P., van Deurzen, C. H. M., Span, P. N., Sweep, F. C. G. J., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.037176 · Cited by 65
Salatino, A., Aversa, I., Battaglia, A. M., Sacco, A., Vito, A. D., Santamaria, G., Chirillo, R., Veltri, P., Tradigo, G., Cello, A. D., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3461251 · Cited by 65
Kim, D.-H., Kim, J., Kim, E., Na, H.-K., Cha, Y.-N., Chung, J. H., & Surh, Y. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp012 · Cited by 64
Fenton reactions drive nucleotide and ATP syntheses in cancer
Sun, H., Zhang, C., Cao, S., Sheng, T., Dong, N., & Xu, Y. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy039 · Cited by 64
Siegel, A. B., Narayan, R., Rodriguez, R., Goyal, A., Jacobson, J. S., Kelly, K. M., Ladas, E. J., Lunghofer, P. J., Hansen, R. J., Gustafson, D. L., et al. (2013) · Integrative Cancer Therapies · doi:10.1177/1534735413490798 · Cited by 63
miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma
Babu, K. R., & Muckenthaler, M. U. (2019) · Scientific Reports · doi:10.1038/s41598-018-35947-7 · Cited by 63
Aung, W., Hasegawa, S., Furukawa, T., & Saga, T. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm090 · Cited by 62 · cited 1×
“Similarly, mesothelioma cells overexpress FTH1 to protect against asbestos-induced ROS and its knockdown rendered them more sensitive to apoptosis (120).”
BackgroundRepositioning the Old Fungicide Ciclopirox for New Medical Uses
Shen, T., & Huang, S. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160530151209 · Cited by 62
You, K., Su, F., Liu, L., Lv, X., Zhang, J., Zhang, Y., & Liu, B. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3055-4 · Cited by 62
Kunos, C. A., Andrews, S. J., Moore, K. N., Chon, H. S., & Ivy, S. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01067 · Cited by 62
Wu, L., Du, Y., Lok, J. M., Lo, E. H., & Xing, C. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.13023 · Cited by 61
Zeidner, J. F., Karp, J. E., Blackford, A. L., Smith, B. D., Gojo, I., Gore, S. D., Levis, M. J., Carraway, H. E., Greer, J. M., Ivy, S. P., et al. (2013) · Haematologica · doi:10.3324/haematol.2013.097246 · Cited by 61
Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
Saeki, I., Yamamoto, N., Yamasaki, T., Takami, T., Maeda, M., Fujisawa, K., Iwamoto, T., Matsumoto, T., Hidaka, I., Ishikawa, T., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i40.8967 · Cited by 61
Horniblow, R. D., Bedford, M., Hollingworth, R., Evans, S. C., Sutton, E., Lal, N., Beggs, A. D., Iqbal, T. H., & Tselepis, C. (2017) · Cancer Science · doi:10.1111/cas.13234 · Cited by 61
Deng, Z., Manz, D. H., Torti, S. V., & Torti, F. M. (2017) · Oncotarget · doi:10.18632/oncotarget.19288 · Cited by 61
Epis, M. R., Giles, K. M., Kalinowski, F. C., Barker, A. J., Cohen, R. J., & Leedman, P. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.374686 · Cited by 59
Self-citationLee, S., Song, A., & Eo, W. K. (2016) · Journal of Cancer · doi:10.7150/jca.14797 · Cited by 59
Targeting Histone Demethylases in MYC-Driven Neuroblastomas with Ciclopirox
Yang, J., Milasta, S., Hu, D., AlTahan, A. M., Interiano, R. B., Zhou, J., Davidson, J. T., Low, J. A., Lin, W., Bao, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0826 · Cited by 59
Miyazawa, M., Bogdan, A. R., Hashimoto, K., & Tsuji, Y. (2018) · RNA · doi:10.1261/rna.063941.117 · Cited by 59
Pogribny, I. P., Tryndyak, V., Pogribna, M., Shpyleva, S., Surratt, G., da Costa, G. G., & Beland, F. A. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1855 · Cited by 57
Sala, R., Jefferies, W. A., Walker, B., Yang, J. W., Tiong, J., Law, S. K. A., Carlevaro, M. F., Marco, E. D., Vacca, A., Cancedda, R., et al. (2002) · European Journal of Cell Biology · doi:10.1078/0171-9335-00280 · Cited by 57
Harima, H., Kaino, S., Takami, T., Shinoda, S., Matsumoto, T., Fujisawa, K., Yamamoto, N., Yamasaki, T., & Sakaida, I. (2016) · BMC Cancer · doi:10.1186/s12885-016-2744-9 · Cited by 57
Doxorubicin loaded ferritin nanoparticles for ferroptosis enhanced targeted killing of cancer cells
Yang, R., Li, Y., Wang, X., Yan, J., Pan, D., Xu, Y., Wang, L., & Yang, M. (2019) · RSC Advances · doi:10.1039/c9ra04478g · Cited by 57
Conditional deletion of ferritin H in mice reduces B and T lymphocyte populations
Vanoaica, L., Richman, L., Jaworski, M., Darshan, D., Luther, S. A., & Kühn, L. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089270 · Cited by 56
Mobilization of iron from ferritin: New steps and details
La, A., Nguyen, T., Tran, K., Sauble, E., Tu, D., Gonzalez, A., Kidane, T. Z., Soriano, C., Morgan, J., Doan, M., et al. (2018) · Metallomics · doi:10.1039/c7mt00284j · Cited by 56
Iron chelator-induced apoptosis via the ER stress pathway in gastric cancer cells
Kim, J. L., Lee, D.-H., Na, Y. J., Kim, B. R., Jeong, Y. A., Lee, S. I., Kang, S., Joung, S. Y., Lee, S., Oh, S. C., et al. (2016) · Tumor Biology · doi:10.1007/s13277-016-4878-4 · Cited by 56
Overexpression of iron regulatory protein 1 suppresses growth of tumor xenografts
Chen, G., Fillebeen, C., Wang, J., & Pantopoulos, K. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl210 · Cited by 55
Protein degradation and iron homeostasis
Thompson, J. W., & Bruick, R. K. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.02.003 · Cited by 54
Kim (2010) · International Journal of Oncology · doi:10.3892/ijo.2010.854 · Cited by 54
Al-Akra, L., Bae, D.-H., Sahni, S., Huang, M., Park, K. C., Lane, D. J. R., Jansson, P. J., & Richardson, D. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.772699 · Cited by 54
Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway
Cui, C., Cheng, X., Yan, L., Ding, H., Guan, X., Zhang, W., Tian, X., & Hao, C. (2019) · Cancer Management and Research · doi:10.2147/cmar.s198911 · Cited by 54
Decreased expression of ferroportin in prostate cancer
Xue, D., Zhou, C., Shi, Y., Lü, H., & He, X. (2015) · Oncology Letters · doi:10.3892/ol.2015.3363 · Cited by 53
Role of zinc and iron chelation in apoptosis mediated by tachpyridine, an anti-cancer iron chelator
Zhao, R., Planalp, R. P., Ma, R., Greene, B. T., Jones, B. T., Brechbiel, M. W., Torti, F. M., & Torti, S. V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.036 · Cited by 53
Regulation of the divalent metal ion transporter via membrane budding
Mackenzie, K., Foot, N. J., Anand, S., Dalton, H. E., Chaudhary, N., Collins, B. M., Mathivanan, S., & Kumar, S. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.11 · Cited by 53
Chua, A. C. G., Knuiman, M. W., Trinder, D., Divitini, M., & Olynyk, J. K. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.129411 · Cited by 53
Self-citationFerritin Content in Human Cancerous and Noncancerous Colonic Tissue
Vaughn, C. B., Weinstein, R. E., Bond, B. H., Rice, R., Vaughn, R., McKendrick, A., Ayad, G., Rockwell, M. A., & Rocchio, R. (1987) · Cancer Investigation · doi:10.3109/07357908709020300 · Cited by 52
Li, P., Zheng, X., Shou, K., Niu, Y., Jian, C., Zhao, Y., Yi, W., Hu, X., & Yu, A. (2016) · PubMed · Cited by 52
Lehmann, U., Wingen, L. U., Brakensiek, K., Wedemeyer, H. H., Becker, T., Heim, A., Metzig, K., Hasemeier, B., Kreipe, H. H., & Flemming, P. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm082 · Cited by 51
Cited by
Inhibition of ferroptosis and iron accumulation alleviates pulmonary fibrosis in a bleomycin model
Pei, Z., Qin, Y., Fu, X., Yang, F., Huo, F., Liang, X., Wang, S., Cui, H., Lin, P., Zhou, G., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102509 · Cited by 269
Iron Metabolism: State of the Art in Hypoxic Cancer Cell Biology
Liu, S., Cao, X., Wang, D., & Zhu, H. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109199 · Cited by 31
Metadata
- Authors
- Brown, R. A. M., Richardson, K. L., Kabir, T. D., Trinder, D., Ganss, R., & Leedman, P. J.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-04-09
- Volume
- 10
- Pages
- 476-476
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3015635259
- Cited by
- 278
- References
- 246
- FWCI
- 18.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.